SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Bernhard Steiner, Rahim Masood, Kaspar Rufibach, Dunja Niedrist, Oliver Kundert, Mariluce Riegel, Albert Schinzel, An unexpected finding: younger fathers have a higher risk for offspring with chromosomal aneuploidies, European Journal of Human Genetics, 2015, 23, 4, 466

    CrossRef

  2. 2
    Praveen Thummalakunta, Surekha Panditi, Approach to Screening for Aneuploidy in First Trimester, Journal of Fetal Medicine, 2014, 1, 4, 175

    CrossRef

  3. 3
    Chan-Kyung J. Cho, Eleftherios P. Diamandis, Application of proteomics to prenatal screening and diagnosis for aneuploidies, Clinical Chemistry and Laboratory Medicine, 2011, 49, 1

    CrossRef

  4. You have free access to this content4
    Kypros H. Nicolaides, Screening for fetal aneuploidies at 11 to 13 weeks, Prenatal Diagnosis, 2011, 31, 1
  5. 5
    Chan-Kyung J. Cho, Andrei P. Drabovich, Ihor Batruch, Eleftherios P. Diamandis, Verification of a biomarker discovery approach for detection of Down syndrome in amniotic fluid via multiplex selected reaction monitoring (SRM) assay, Journal of Proteomics, 2011, 74, 10, 2052

    CrossRef

  6. 6
    N Neely Kazerouni, Bob Currier, Linda Malm, Susan Riggle, Christina Hodgkinson, Sylvia Smith, Corinna Tempelis, Fred Lorey, Amber Davis, Laura Jelliffe-Pawlowski, Lynn Walton-Haynes, Marie Roberson, Triple-Marker Prenatal Screening Program for Chromosomal Defects, Obstetrics & Gynecology, 2009, 114, 1, 50

    CrossRef

  7. 7
    Valerie Seror, Fitting observed and theoretical choices – women's choices about prenatal diagnosis of Down syndrome, Health Economics, 2008, 17, 5
  8. 8
    George M. Savva, Joan K. Morris, David E. Mutton, Eva Alberman, Maternal age-specific fetal loss rates in Down syndrome pregnancies, Prenatal Diagnosis, 2006, 26, 6
  9. 9
    Natasha Davidson, Jane Halliday, Merilyn Riley, James King, Influence of prenatal diagnosis and pregnancy termination of fetuses with birth defects on the perinatal mortality rate in Victoria, Australia, Paediatric and Perinatal Epidemiology, 2005, 19, 1
  10. 10
    Jenny Bourke, Carol Bower, Eve Blair, Adrian Charles, Matthew Knuiman, The effect of terminations of pregnancy for fetal abnormalities on trends in mortality to one year of age in Western Australia, Paediatric and Perinatal Epidemiology, 2005, 19, 4
  11. 11
    Rosa H. Won, Robert J. Currier, Fred Lorey, Dena R. Towner, The timing of demise in fetuses with trisomy 21 and trisomy 18, Prenatal Diagnosis, 2005, 25, 7
  12. 12
    Kypros H. Nicolaides, Nuchal translucency and other first-trimester sonographic markers of chromosomal abnormalities, American Journal of Obstetrics and Gynecology, 2004, 191, 1, 45

    CrossRef

  13. 13
    J. K. Morris, N. J. Wald, D. E. Mutton, E. Alberman, Comparison of models of maternal age-specific risk for Down syndrome live births, Prenatal Diagnosis, 2003, 23, 3
  14. 14
    Sheila Mulvey, Rebecca Zachariah, Kate McIlwaine, Euan M. Wallace, Do women prefer to have screening tests for Down syndrome that have the lowest screen-positive rate or the highest detection rate?, Prenatal Diagnosis, 2003, 23, 10
  15. 15
    S. Choong, L. Rombauts, A. Ugoni, S. Meagher, Ultrasound prediction of risk of spontaneous miscarriage in live embryos from assisted conceptions, Ultrasound in Obstetrics & Gynecology, 2003, 22, 6
  16. 16
    Kypros H. Nicolaides, Victoria Heath, Simona Cicero, Increased fetal nuchal translucency at 11–14 weeks, Prenatal Diagnosis, 2002, 22, 4
  17. 17
    Françoise Muller, François Forestier, Bernard Dingeon, Second trimester trisomy 21 maternal serum marker screening. Results of a countrywide study of 854 902 patients, Prenatal Diagnosis, 2002, 22, 10
  18. 18
    Thomas D. Shipp, Beryl R. Benacerraf, Second trimester ultrasound screening for chromosomal abnormalities, Prenatal Diagnosis, 2002, 22, 4
  19. 19
    Sheila Mulvey, Trang Pham, Katrina Tyzack, Euan M Wallace, Women's preferences for reporting of Down syndrome screening results, Australian and New Zealand Journal of Obstetrics and Gynaecology, 2002, 42, 5
  20. 20
    Kevin Spencer, What is the true fetal loss rate in pregnancies affected by trisomy 21 and how does this influence whether first trimester detection rates are superior to those in the second trimester?, Prenatal Diagnosis, 2001, 21, 9
  21. 21
    M Cioffi, P Gazzerro, C Di Macchia, MT Vietri, A Contursi, R Magnetta, R Colicigno, V Sica, Screening of maternal serum for prenatal Down's syndrome and neural tube defects: an Italian experience, Immuno-analyse & Biologie Spécialisée, 2000, 15, 3, 177

    CrossRef

  22. 22
    Kypros H. Nicolaides, Victoria Heath, Adolfo W. Liao, The 11–14 week scan, Best Practice & Research Clinical Obstetrics & Gynaecology, 2000, 14, 4, 581

    CrossRef

  23. 23
    Tracy Cheffins, Annabelle Chan, Eric A. Haan, Enzo Ranieri, Richard G. Ryall, Rosemary J. Keane, Rosemary Byron-Scott, Heather Scott, Elizabeth M. Gjerde, Anh-Minh Nguyen, Judith H. Ford, Stephen Sykes, The impact of maternal serum screening on the birth prevalence of Down's syndrome and the use of amniocentesis and chorionic villus sampling in South Australia, BJOG: An International Journal of Obstetrics & Gynaecology, 2000, 107, 12
  24. 24
    M. J. M. Wortelboer, B. T. H. M de Wolf, C. C. Verschuuren-Bemelmans, J. Reefhuis, A. Mantingh, J. R. Beekhuis, M. C. Cornel, Trends in live birth prevalence of Down syndrome in the Northern Netherlands 1987–96: the impact of screening and prenatal diagnosis, Prenatal Diagnosis, 2000, 20, 9
  25. 25
    S. Mulvey, E. M. Wallace, Women's knowledge of and attitudes to first and second trimester screening for Down's syndrome, BJOG: An International Journal of Obstetrics & Gynaecology, 2000, 107, 10
  26. 26
    Rosalinde Snijders, Fetal loss in Down syndrome pregnancies, Prenatal Diagnosis, 1999, 19, 12
  27. You have free access to this content27
    J. K. Morris, N. J. Wald, H. C. Watt, Fetal loss in Down syndrome pregnancies, Prenatal Diagnosis, 1999, 19, 2
  28. 28
    Miriam Kuppermann, David Feeny, Elena Gates, Samuel F. Posner, Bruce Blumberg, A. Eugene Washington, Preferences of women facing a prenatal diagnostic choice: long-term outcomes matter most, Prenatal Diagnosis, 1999, 19, 8
  29. 29
    Annick-Camille Dumaret, Catherine de Vigan, Claire Julian-Reynier, Janine Goujard, Dominique Rosset, Ségolène Aymé, Adoption and fostering of babies with Down syndrome: a cohort of 593 cases, Prenatal Diagnosis, 1998, 18, 5
  30. 30
    Valérie Seror, Nathalie Costet, Down syndrome serum marker screening: decision criteria and implicit values, Health Policy, 1998, 43, 1, 83

    CrossRef

  31. 31
    Isabelle C. Bray, David E. Wright, Estimating the spontaneous loss of Down syndrome fetuses between the times of chorionic villus sampling, amniocentesis and livebirth, Prenatal Diagnosis, 1998, 18, 10
  32. 32
    Isabelle Bray, David E. Wright, Chris Davies, Ernest B. Hook, Joint estimation of Down syndrome risk and ascertainment rates: a meta-analysis of nine published data sets, Prenatal Diagnosis, 1998, 18, 1
  33. 33
    Review article, Journal of Perinatal Medicine, 1995, 23, 6, 421

    CrossRef